Deal Making

Featured on Deal Making

ABL and KaliVir collaborate to advance oncolytic viruses
Deal-Making
ABL and KaliVir collaborate to advance oncolytic virusesABL and KaliVir collaborate to advance oncolytic viruses

ABL will provide materials and manufacture KaliVir Therapeutics’ oncolytic viruses for its forthcoming clinical trial.

byMillie Nelson, Editor
Jul 12, 2022
|
1 Min Read
Exothera selected by Vaccizone to fast-track COVID-19 vax
Deal-Making
Exothera selected by Vaccizone to fast-track COVID-19 vaxExothera selected by Vaccizone to fast-track COVID-19 vax
byMillie Nelson
Jul 11, 2022
2 Min Read
Portage targets adenosine pathway with Tarus acquisition
Deal-Making
Portage targets adenosine pathway with Tarus acquisitionPortage targets adenosine pathway with Tarus acquisition
byMillie Nelson
Jul 8, 2022
2 Min Read
AstraZeneca forks out $100m to acquire TeneoTwo
Deal-Making
AstraZeneca forks out $100m to acquire TeneoTwoAstraZeneca forks out $100m to acquire TeneoTwo
byMillie Nelson
Jul 6, 2022
2 Min Read
Pfizer licenses plasmid DNA-alternative tech from Touchlight
Deal-Making
Pfizer licenses plasmid DNA-alternative tech from TouchlightPfizer licenses plasmid DNA-alternative tech from Touchlight
byMillie Nelson
Jul 6, 2022
1 Min Read
Terumo and GenCure sign CGT solutions deal
Deal-Making
Terumo and GenCure sign CGT solutions dealTerumo and GenCure sign CGT solutions deal
byMillie Nelson
Jul 5, 2022
2 Min Read

More from Deal Making

Cytiva and Bayer partner to develop allogenic cell therapy platform
Deal-Making
Cytiva and Bayer partner to develop allogenic cell therapy platform
Cytiva and Bayer partner to develop allogenic cell therapy platform
Jul 5, 2022
|
2 Min Read
byMillie Nelson, Editor
Astellas turns to next-gen ADCs with $90m Sutro partnership
Deal-Making
Astellas turns to next-gen ADCs with $90m Sutro partnership
Astellas turns to next-gen ADCs with $90m Sutro partnership
Jun 29, 2022
|
2 Min Read
byDan Stanton, Editorial director
invoX acquires bispecific firm F-Star for $161m
Deal-Making
invoX acquires bispecific firm F-Star for $161m
invoX acquires bispecific firm F-Star for $161m
Jun 27, 2022
|
2 Min Read
byRichard Daverman
Charles River bags Ziphius contract in ever-growing RNA space
Deal-Making
Charles River bags Ziphius contract in ever-growing RNA space
Charles River bags Ziphius contract in ever-growing RNA space
Jun 23, 2022
|
2 Min Read
byDan Stanton, Editorial director
Galapagos makes ‘surprising’ cell therapy pivot via CellPoint and AboundBio buy
Deal-Making
Galapagos makes ‘surprising’ cell therapy pivot via CellPoint and AboundBio buy
Galapagos makes ‘surprising’ cell therapy pivot via CellPoint and AboundBio buy
Jun 23, 2022
|
2 Min Read
byDan Stanton, Editorial director
CGT Catapult partnership to develop AAV gene therapies for dementia
Deal-Making
CGT Catapult partnership to develop AAV gene therapies for dementia
CGT Catapult partnership to develop AAV gene therapies for dementia
Jun 22, 2022
|
2 Min Read
byMillie Nelson, Editor
Pfizer takes $95m stake in Lyme disease vaccine partner Valneva
Bioprocess Insider
Pfizer takes $95m stake in Lyme disease vaccine partner Valneva
Pfizer takes $95m stake in Lyme disease vaccine partner Valneva
Jun 21, 2022
|
2 Min Read
byDan Stanton, Editorial director
Merck buying Seagen would make strategic sense, says analyst
Deal-Making
Merck buying Seagen would make strategic sense, says analyst
Merck buying Seagen would make strategic sense, says analyst
Jun 20, 2022
|
2 Min Read
byDan Stanton, Editorial director
MilliporeSigma and Agilent aim to extend PAT to real-time release
Deal-Making
MilliporeSigma and Agilent aim to extend PAT to real-time release
MilliporeSigma and Agilent aim to extend PAT to real-time release
Jun 17, 2022
|
2 Min Read
byGareth Macdonald
Univercells partners with CBET to prep students for CGT space
Deal-Making
Univercells partners with CBET to prep students for CGT space
Univercells partners with CBET to prep students for CGT space
Jun 16, 2022
|
2 Min Read
byMillie Nelson, Editor
Charles River and ASC partner to manufacture gene therapy
Deal-Making
Charles River and ASC partner to manufacture gene therapy
Charles River and ASC partner to manufacture gene therapy
Jun 15, 2022
|
2 Min Read
byMillie Nelson, Editor
Curia and Replicate partner to create srRNA platform
Deal-Making
Curia and Replicate partner to create srRNA platform
Curia and Replicate partner to create srRNA platform
Jun 13, 2022
|
2 Min Read
byMillie Nelson, Editor
Coave and ABL partner to develop gene therapy manufacturing processes
Deal-Making
Coave and ABL partner to develop gene therapy manufacturing processes
Coave and ABL partner to develop gene therapy manufacturing processes
Jun 10, 2022
|
2 Min Read
byMillie Nelson, Editor
MigVax taps Catalent to deliver COVID-19 vaccine orally
Upstream & Downstream Processing
MigVax taps Catalent to deliver COVID-19 vaccine orally
MigVax taps Catalent to deliver COVID-19 vaccine orally
Jun 9, 2022
|
2 Min Read
byDan Stanton, Editorial director
Resilience continues capacity march with further $625m of funding
Deal-Making
Resilience continues capacity march with further $625m of funding
Resilience continues capacity march with further $625m of funding
Jun 8, 2022
|
2 Min Read
byDan Stanton, Editorial director
Bristol-Myers forks out $4.1bn to acquire Turning Point Therapeutics
Deal-Making
Bristol-Myers forks out $4.1bn to acquire Turning Point Therapeutics
Bristol-Myers forks out $4.1bn to acquire Turning Point Therapeutics
Jun 6, 2022
|
1 Min Read
byBPI Staff
Regeneron to supply Elicio with Libtayo for combo cancer vaccine study
Therapeutic Class
Regeneron to supply Elicio with Libtayo for combo cancer vaccine study
Regeneron to supply Elicio with Libtayo for combo cancer vaccine study
Jun 2, 2022
|
2 Min Read
byGareth Macdonald
Evotec expands cell therapy capabilities with Rigenerand buy
Deal-Making
Evotec expands cell therapy capabilities with Rigenerand buy
Evotec expands cell therapy capabilities with Rigenerand buy
May 31, 2022
|
2 Min Read
byMillie Nelson, Editor
GSK boosting vaccine tech through $2.1bn Affinivax buy
Deal-Making
GSK boosting vaccine tech through $2.1bn Affinivax buy
GSK boosting vaccine tech through $2.1bn Affinivax buy
May 31, 2022
|
2 Min Read
byDan Stanton, Editorial director
Avantor and Cytovance team to address $1.5bn plasmid DNA market
Deal-Making
Avantor and Cytovance team to address $1.5bn plasmid DNA market
Avantor and Cytovance team to address $1.5bn plasmid DNA market
May 17, 2022
|
2 Min Read
byDan Stanton, Editorial director
Korean CDMO enters US with BMS plant buy
Facilities & Capacity
Korean CDMO enters US with BMS plant buy
Korean CDMO enters US with BMS plant buy
May 16, 2022
|
2 Min Read
byMillie Nelson, Editor
ALSA latest VC firm to contract Lonza to service its portfolio
Deal-Making
ALSA latest VC firm to contract Lonza to service its portfolio
ALSA latest VC firm to contract Lonza to service its portfolio
May 13, 2022
|
2 Min Read
byDan Stanton, Editorial director
Bora Pharmaceuticals bolsters CDMO biz with Eden buy
Facilities & Capacity
Bora Pharmaceuticals bolsters CDMO biz with Eden buy
Bora Pharmaceuticals bolsters CDMO biz with Eden buy
May 13, 2022
|
2 Min Read
byMillie Nelson, Editor
Dover shells out $225m for bio-control instruments firm Malema
Deal-Making
Dover shells out $225m for bio-control instruments firm Malema
Dover shells out $225m for bio-control instruments firm Malema
May 11, 2022
|
1 Min Read
byDan Stanton, Editorial director
PE firm Astorg to buy CordenPharma from ICIG
Deal-Making
PE firm Astorg to buy CordenPharma from ICIG
PE firm Astorg to buy CordenPharma from ICIG
May 4, 2022
|
2 Min Read
byMillie Nelson, Editor
Quell and Cellistic partner to develop cell therapy platform
Deal-Making
Quell and Cellistic partner to develop cell therapy platform
Quell and Cellistic partner to develop cell therapy platform
May 2, 2022
|
2 Min Read
byMillie Nelson, Editor
US Gov awards $10.6m freeze-dried plasma contract to Terumo
Deal-Making
US Gov awards $10.6m freeze-dried plasma contract to Terumo
US Gov awards $10.6m freeze-dried plasma contract to Terumo
May 2, 2022
|
2 Min Read
byMillie Nelson, Editor
NorthX Biologics inks vaccine partnership with Abera
Deal-Making
NorthX Biologics inks vaccine partnership with Abera
NorthX Biologics inks vaccine partnership with Abera
Apr 27, 2022
|
2 Min Read
byMillie Nelson, Editor
China’s I-Mab allegedly seeking asset or company sale
Deal-Making
China’s I-Mab allegedly seeking asset or company sale
China’s I-Mab allegedly seeking asset or company sale
Apr 26, 2022
|
3 Min Read
byRichard Daverman
Catalent pays Erytech $44.5m for NJ cell therapy plant
Facilities & Capacity
Catalent pays Erytech $44.5m for NJ cell therapy plant
Catalent pays Erytech $44.5m for NJ cell therapy plant
Apr 26, 2022
|
2 Min Read
byMillie Nelson, Editor

Webinars

Ask the Expert webcasts
ATE Webcasts
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Register Now: Big Impact from Small Samples: Harnessing High-Precision Tunable Laser Spectroscopy for Complex Bioprocessing Analysis
Ask the Expert webcasts
ATE Webcasts
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Register Now: Advancing mRNA and CircRNA-based Vaccines and Therapeutics in CMC: From Process Development to Analytics
Insider News
See all
Jun 5 - Jun 6, 2024
Exploit Advances in Exosomes to Improve Efficiencies in Drug Delivery: Connect with senior-level executives and scientists who will share new data and novel case studies on advancing EV products through clinical stage towards commercialization
Learn More

Innovative Technology

Nagase Trehalose SG
Sponsored Content
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG
Innovative Impurity Reduction in Harvesting Process With TREHALOSE SG

Jan 9, 2025

Bruker Tornado Spectroscopy
Sponsored Content
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy
Monitoring and Controlling Upstream Bioprocesses with Raman Spectroscopy

Dec 1, 2024

Thermo Fisher White Paper
Sponsored Content
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies
Peptones: A Powerful Tool for Manufacturing Complex Protein Therapies

Nov 21, 2024

Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.
Subscribe